BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Pharmacogenetics
,
Doxorubicin
,
rs7903146
,
PRKCA
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bis 1
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation.
Long noncoding RNA H19 promotes vascular calcification by repressing the Bax inhibitor 1/optic atrop…
TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lys…
BI-1 ameliorates myocardial injury by activating the mitochondrial unfolded protein response and FUN…
Induction of Systemic Resistance to Tobacco mosaic virus in Tomato through Foliar Application of Bac…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluating Safety and Effectiveness of N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-oct…
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy …
Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without…
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver…
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients Wi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ